Pathophysiology of Erectile Dysfunction: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 63: | Line 63: | ||
** '''<span style="color:#ff0000">β-blockers:</span>''' | ** '''<span style="color:#ff0000">β-blockers:</span>''' | ||
*** '''<span style="color:#ff0000">Non-selective β antagonists (e.g. propranolol) are associated with ED</span>''' | *** '''<span style="color:#ff0000">Non-selective β antagonists (e.g. propranolol) are associated with ED</span>''' | ||
*** '''<span style="color:#ff0000">β1-selective antagonists (e.g. acebutolol, atenolol, bisoprolol, metoprolol) are not associated with ED</span>''' | *** '''<span style="color:#ff0000">β1-selective antagonists (e.g. acebutolol, atenolol, bisoprolol, metoprolol, esmolol) are not associated with ED</span>''' | ||
* '''<span style="color:#ff0000">Methyldopa, a centrally acting drug, is associated with ED</span>''' | * '''<span style="color:#ff0000">Methyldopa, a centrally acting drug, is associated with ED</span>''' | ||